Market Report
London close: Stocks drop amid global growth worries, Brexit exhaustion
London stocks finished lower on Friday, albeit off their worst levels of the session, following the release of weak Chinese data and after Theresa May returned home from her EU charm offensive empty-handed.
Director dealings: Plus500 co-founder lowers stake
Plus500 co-founder Alon Gonen sold 2. 25m ordinary shares in the FTSE 250-listed trading service on Friday.
US November industrial output comes in slightly below forecasts
US industrial production rose last month at its fastest clip since August and economists believed stronger readings lay ahead.
Broker tips: Bellway, MJ Gleeson, Persimmon, Bovis, Crest Nicholson, Telford Homes, McCarthy and Stone
In broker action, analysts at Canaccord Genuity said there was some "extremely attractive" valuations among housebuilders but this is balanced by macroeconomic risks that are "exceptionally high".
Sector movers: China data hits miners, oil retreats
Industrial metals, miners and other resources stocks were the main weight around the London market's neck on Friday after China data sparked renewed concerns.
Walcom CFO resigns amid spat with largest customer
Walcom chief financial officer Albert Wong has resigned as a director of the company, effective immediately.
FTSE 100 movers: Miners and housebuilders decline; GVC gains
London’s FTSE 100 was down 0. 3% at 6,848. 02 in afternoon trade on Friday, with housebuilders and miners under pressure.
Metal Tiger's new joint venture granted licence extensions
Strategic natural resource opportunities investor Metal Tiger updated the market on exploration activities of its new joint venture, Tshukudu Exploration, in the Kalahari Copper Belt in Botswana on Friday.
FTSE 250 movers: G4S sinks but Indivior rises on courtroom drama
London's FTSE 250 was down 0. 84% at 17,669. 60 in afternoon trade on Friday, with G4S leading the fallers as its share price levelled out following a Thursday jump.
Dosing begins in Faron's study of 'Clevegen' drug
Clinical stage biopharmaceutical company Faron Pharmaceuticals announced on Friday that the first patient has successfully been dosed in the phase I/II MATINS study of Clevegen, its wholly-owned novel precision cancer immunotherapy drug.
US open: Stocks dragged down by weak Chinese data
Wall Street stocks opened lower on Friday following the release of some weak Chinese data earlier in the day that spread concerns regarding the state of the world's second-largest economy.
Modern Water sells desalination unit to Oman safari park
Modern Water has sold an ‘AquaPak’ desalination plant in Oman, it announced on Friday.
Housebuilders look attractive to Canaccord, but depends on macro
There are some "extremely attractive" valuations among housebuilders but this is balanced by macroeconomic risk that are "exceptionally high", said broker Canaccord Genuity on Friday.
US retail sales volumes 'strong' in November
US retail sales volumes rose as forecast last month, alongside upwards revisions to prior months' data, resulting in a "strong" report overall, according to analysts, despite the drag from lower gasoline prices.
Kodal Minerals narrows loss as it works towards production at Bougouni
Mineral development and exploration company Kodal Minerals announced its unaudited interim results for the six months ended 30 September on Friday, with its loss narrowing to £0. 34m year-on-year, from £0. 53m.
New-look Chaarat Gold returns to trading on AIM
Chaarat Gold published its admission document relating to the proposed acquisition of Kapan Mining and Processing Company on Friday, and announced the re-admission of its ordinary shares to trading on the AIM market.
Parliament to vote on FOBTs next week, GVC shares fly
Shares in GVC Holdings were galloping higher on Friday after the confirmation that a parliamentary vote will be held next week on legislation to crack down on fixed-odds betting terminals.
EQTEC draws third tranche from $10m financing facility
Waste gas-to-energy technology solutions company EQTEC has drawn down a third tranche of $0. 86m, under its $10m financing facility provided by Cuart Investments Fund and associates, which was announced on 5 July and 27 September.
McCarthy & Stone faces 'significant headwinds', reckons Berenberg
Analysts at Berenberg believe retirement home construction outfit McCarthy & Stone's trading will remain challenged, despite a "solid start" to its transformation plan.
LSE poaches new chairman from Experian
London Stock Exchange has appointed Experian’s Donald Robert as its new chairman, succeeding Donald Brydon, who will leave after the annual general meeting next May.